By John Harbison|2019-04-03T14:24:08-08:00April 1, 2019|Tech Coast Angels Portfolio Companies in the Press|Comments Off on Savara Initiates Phase 2a Clinical Study of Molgradex for the Treatment of NTM Lung Infection in People Living with Cystic Fibrosis
